Publications by authors named "E M Ramsey"

Objective: To assess the impact of the COVID-19 pandemic on the state-level enteric disease workforce and routine enteric disease surveillance and outbreak investigation activities in the western United States.

Design And Setting: Key informant interviews conducted using bidirectional video from March to April 2022.

Participants: Enteric disease epidemiologists at state public health agencies in the western states served by the Colorado and Washington Integrated Food Safety Centers of Excellence.

View Article and Find Full Text PDF

Introduction: Methadone is a medically necessary and lifesaving medication for many patients with opioid use disorder. To adequately address these patients' needs, methadone should be offered in the hospital, but barriers exist that limit its continuation upon discharge. The code of federal regulations allows for methadone dosing as an inpatient as well as outpatient dispensing for up to three days to facilitate linkage to treatment.

View Article and Find Full Text PDF

This retrospective chart review of patients less than 18 years old with pulmonary arterial hypertension (PAH) receiving selexipag was conducted to describe selexipag dosing practices, impact on concomitant PAH therapies, and the safety and efficacy of selexipag. Twenty-seven patients aged 1-17 years started a median dose of oral selexipag 100 µg twice daily. Therapy was increased by a median of 100 µg twice daily every 6 days to a maximally tolerated median dose of 800 µg twice daily.

View Article and Find Full Text PDF

Metastasis is the most dreaded outcome after a breast cancer diagnosis, and little is known regarding what triggers or promotes breast cancer to spread distally, or how to prevent or eradicate metastasis effectively. Bilateral breast cancers are an uncommon form of breast cancers. In our study, a percentage of bilateral breast cancers were clonally related based on copy number variation profiling.

View Article and Find Full Text PDF
Article Synopsis
  • * Gabapentin was given to 22.9% of infants studied, showing a trend of increased use over time, and those who received it tended to have longer hospital stays and chest tube durations.
  • * Results indicated a slight decrease in benzodiazepine use for infants taking gabapentin, but no significant change in opioid use, suggesting that further research is needed to fully understand gabapentin's role in postoperative care.
View Article and Find Full Text PDF